SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Pham L)
 

Sökning: WFRF:(Pham L) > (2020-2024) > Treatment of allerg...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00013987naa a2201405 4500
001oai:DiVA.org:uu-432374
003SwePub
008210119s2020 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:145407474
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4323742 URI
024a https://doi.org/10.1186/s13601-020-00342-x2 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1454074742 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a for2 swepub-publicationtype
100a Bédard, A.u ISGlobal, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; Univ Pompeu Fabra UPF, Barcelona, Spain4 aut
2451 0a Treatment of allergic rhinitis during and outside the pollen season using mobile technology :b A MASK study
264 c 2020-12-09
264 1b Wiley,c 2020
338 a electronic2 rdacarrier
500 a Correction in: CLINICAL AND TRANSLATIONAL ALLERGY, Volume 12, Issue 3, Article Number e12126, DOI 10.1002/clt2.12126
520 a BackgroundThe analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users.MethodsThe Allergy Diary–MASK-air–mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis.Results9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines.ConclusionsThis study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Lungmedicin och allergi0 (SwePub)302192 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Respiratory Medicine and Allergy0 (SwePub)302192 hsv//eng
653 a Allergic rhinitis
653 a Anti-histamines
653 a Corticosteroids
653 a ICT
653 a Mobile health
653 a MASK
653 a Treatment
700a Basagaña, X.u ISGlobal, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; Univ Pompeu Fabra UPF, Barcelona, Spain4 aut
700a Anto, J. M.u ISGlobal, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; Univ Pompeu Fabra UPF, Barcelona, Spain; IMIM Hosp del Mar Res Inst, Barcelona, Spain4 aut
700a Garcia-Aymerich, J.u ISGlobal, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; Univ Pompeu Fabra UPF, Barcelona, Spain4 aut
700a Devillier, P.u Univ Paris Saclay, Pole Malad Voies Resp, UPRES EA220, Hop Foch, Suresnes, France4 aut
700a Arnavielhe, S.u KYomed INNOV, Montpellier, France4 aut
700a Bedbrook, A.u CHU Montpellier, Montpellier, France4 aut
700a Onorato, G. L.u CHU Montpellier, Montpellier, France4 aut
700a Czarlewski, W.u Med Consulting Czarlewski, Levallois Perret, France4 aut
700a Murray, R.u Research fellow, OPC, and Director, Cambridge, UK; Medscript, Paraparaumu, New Zealand4 aut
700a Almeida, R.u Univ Porto, Fac Med, Lda Porto, Portugal4 aut
700a Fonseca, J. A.u Univ Porto, Fac Med, Lda Porto, Portugal; MEDIDA Lda, Porto, Portugal4 aut
700a Correia da Sousa, J.u Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal4 aut
700a Costa, E.u Univ Porto Porto4Ageing, Fac Pharm, Porto, Portugal; Univ Porto Porto4Ageing, Competence Ctr Act & Hlth Ageing, Porto, Portugal.;Univ Porto Porto4Ageing, Fac Pharm, REQUINTE, UCIBIO, Porto, Portugal4 aut
700a Morais-Almeida, M.u CUF Descobertas Hosp, Allergy Ctr, Lisbon, Portugal4 aut
700a Todo-Bom, A.u Ctr Hosp Univ Coimbra, Imunoalergol, Coimbra, Portugal; Univ Coimbra, Fac Med, Coimbra, Portugal4 aut
700a Cecchi, L.u USL Toscana Ctr, SOS Allergol & Clin Immunol, Prato, Italy4 aut
700a De Feo, G.u Univ Salerno, Dept Med Surg & Dent, Scuola Med Salernitana, Salerno, Italy4 aut
700a Illario, M.u Federico II Univ Hosp Naples, Div Hlth Innovat, R&D, Naples, Italy; DISMET, Naples, Italy4 aut
700a Menditto, E.u Univ Naples Federico II, CIRFF, Naples, Italy4 aut
700a Monti, R.u Univ Torino, Mauriziano Hosp, Dept Med Sci, Allergy & Clin Immunol Unit, Turin, Italy4 aut
700a Stellato, C.u Univ Bari, Unit Geriatr Immunoallergol, Med Sch, Bari, Italy4 aut
700a Ventura, M. T.u Sorbonne Univ, Med Sch St Antoine, Epidemiol Allerg & Resp Dis, INSERM, Dept Inst Pierre Louis Epidemiol & Publ Hlth, Paris, France4 aut
700a Annesi-Maesano, I.u Sorbonne Univ, Med Sch St Antoine, Epidemiol Allerg & Resp Dis, INSERM, Dept Inst Pierre Louis Epidemiol & Publ Hlth, Paris, France4 aut
700a Bosse, I.u La Rochelle, France4 aut
700a Fontaine, J. F.u Reims, France4 aut
700a Pham-Thi, N.u Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France4 aut
700a Thibaudon, M.u RNSA Reseau Natl Surveillance Aerobiol, Brussieu, France4 aut
700a Schmid-Grendelmeier, P.u Univ Hosp Zurich, Dept Dermatol, Allergy Unit, Zurich, Switzerland4 aut
700a Spertini, F.u CHU Vaudois, Serv Immunol & Allergie, Lausanne, Switzerland4 aut
700a Chavannes, N. H.u Leiden Univ Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands4 aut
700a Fokkens, W. J.u Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, AMC, Amsterdam, Netherlands4 aut
700a Reitsma, S.u Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, AMC, Amsterdam, Netherlands4 aut
700a Dubakiene, R.u Vilnius Univ, Med Fac, Clin Chest Dis Immunol & Allergol, Vilnius, Lithuania4 aut
700a Emuzyte, R.u Vilnius Univ, Fac Med, Clin Childrens Dis, Vilnius, Lithuania4 aut
700a Kvedariene, V.u Institute of Biomedical Sciences, Vilnius University, Institute of Clinical Medicine, Vilnius, Lithuania4 aut
700a Valiulis, A.u Vilnius University Institute of Clinical Medicine, Clinic of Children’s Diseases, Department of Public Health, and Institute of Health Sciences, Vilnius, Lithuania; European Academy of Paediatrics, EAP/UEMS-SP), Brussels, Belgium4 aut
700a Kuna, P.u Med Univ Lodz, Barlicki Univ Hosp, Div Internal Med Asthma & Allergy, Lodz, Poland4 aut
700a Samolinski, B.u Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland4 aut
700a Klimek, L.u Ctr Rhinol & Allergol, Wiesbaden, Germany4 aut
700a Mösges, R.u Univ Cologne, Med Fac, CRI Clin Res Int Ltd, Inst Med Stat & Computat Biol, Hamburg, Germany4 aut
700a Pfaar, O.u Philipps Univ Marburg, Dept Otorhinolaryngol Head & Neck Surg, Sect Rhinol & Allergy, Univ Hosp Marburg, Marburg, Germany4 aut
700a Shamai, S.u Univ Cologne, Med Fac, CRI Clin Res Int Ltd, Inst Med Stat & Computat Biol, Hamburg, Germany4 aut
700a Roller-Wirnsberger, R. E.u Med Univ Graz, Dept Internal Med, Graz, Austria4 aut
700a Tomazic, P. V.u Department of ENT, Medical University of Graz, Graz, Austria4 aut
700a Ryan, D.u Univ Edinburgh, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland4 aut
700a Sheikh, A.u Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland4 aut
700a Haahtela, T.u Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; Univ Helsinki, Helsinki, Finland4 aut
700a Toppila-Salmi, S.u Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; Univ Helsinki, Helsinki, Finland4 aut
700a Valovirta, E.u Univ Turku, Dept Lung Dis & Clin Immunol, Terveystalo Allergy Clin, Turku, Finland4 aut
700a Cardona, V.u Hosp Valle De Hebron, Dept Internal Med, Allergy Sect, ARADyAL Res Network, Barcelona, Spain4 aut
700a Mullol, J.u Univ Barcelona, Rhinol Unit, ENT Dept, CIBERES, Hosp Clin,Clin & Expt Resp Immunoallergy,IDIBAPS, Barcelona, Spain; Univ Barcelona, Smell Clin, ENT Dept, CIBERES, Hosp Clin, Clin & Expt Resp Immunoallergy, IDIBAPS, Barcelona, Spain4 aut
700a Valero, A.u Univ Barcelona, Pneumol & Allergy Dept, CIBERES, Barcelona, Spain; Univ Barcelona, IDIBAPS, Clin & Expt Resp Immunoallergy, Barcelona, Spain4 aut
700a Makris, M.u Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Dermatol & Venereol 2, Allergy Unit Kalogeromitros, Athens, Greece4 aut
700a Papadopoulos, N. G.u Univ Manchester, Royal Manchester Childrens Hosp Immun, Div Infect & Resp Med, Manchester, Lancs, England; Univ Athens, Athens Gen Childrens Hosp P&A Kyriakou, Allergy Dept, Pediat Clin 2, Athens, Greece4 aut
700a Prokopakis, E. P.u Univ Crete, Dept Otorhinolaryngol, Sch Med, Iraklion, Greece4 aut
700a Psarros, F.u Athens Naval Hosp, Allergy Dept, Athens, Greece4 aut
700a Bachert, C.u Karolinska Institutet4 aut
700a Hellings, P. W.u Univ Amsterdam, Univ Hosp Leuven, Acad Med Ctr, Dept Otorhinolaryngol, Leuven, Netherlands; European Forum Res & Educ Allergy & Airway Dis EU, Brussels, Belgium4 aut
700a Pugin, B.u European Forum Res & Educ Allergy & Airway Dis EU, Brussels, Belgium4 aut
700a Bindslev-Jensen, C.u Odense Univ Hosp, Odense Res Ctr Anaphylaxis ORCA, Dept Dermatol, Odense, Denmark4 aut
700a Eller, E.u Karolinska Institutet4 aut
700a Kull, I.u Karolinska Institutet4 aut
700a Melén, E.u Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sach's Children and Youth Hospital, Södersjukhuset, Sweden4 aut
700a Wickman, M.u Sachs Children & Youth Hosp, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Stockholm, Sweden4 aut
700a De Vries, G.u Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)4 aut
700a van Eerd, M.u Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)4 aut
700a Agache, I.u Peercode BV, Geldermalsen, Netherlands4 aut
700a Ansotegui, I. J.u Transylvania Univ Brasov, Brasov, Romania4 aut
700a Bosnic-Anticevich, S.u Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, NSW, Australia4 aut
700a Cruz, A. A.u Univ Fed Bahia, Nucleo Excelencia Asma, Salvador, BA, Brazil; WHO GARD Planning Grp, Salvador, BA, Brazil4 aut
700a Casale, T.u Univ S Florida, Div Allergy Immunol, Tampa, FL 33620 USA4 aut
700a Ivancevich, J. C.u Serv Alergia & Immunol, Clin Santa Isabel, Buenos Aires, DF, Argentina4 aut
700a Larenas-Linnemann, D. E.u Med Sur Clin Fdn & Hosp, Ctr Excellence Asthma & Allergy, Mexico City, DF, Mexico4 aut
700a Sofev, M.u Finnish Meteorol Inst FMI, Helsinki, Finland4 aut
700a Wallace, D.u Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA4 aut
700a Waserman, S.u McMaster Univ, Dept Med Clin Immunol & Allergy, Hamilton, ON, Canada4 aut
700a Yorgancioglu, A.u Celal Bayar Univ, Fac Med, Dept Pulm Dis, Manisa, Turkey4 aut
700a Laune, D.u KYomed INNOV, Montpellier, France4 aut
700a Bousquet, J.u CHU Montpellier, Montpellier, France; Univ Hosp, Montpellier, France; INSERM, U1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, France; Univ Versailles St Quentin En Yvelines, UMR S 1168, Montigny Le Bretonneux, France; Humboldt Univ, Charite Univ Med Berlin, Berlin, Germany; Comprehens Allergy Ctr, Berlin Inst Hlth, Dept Dermatol & Allergy, Berlin, Germany4 aut
710a ISGlobal, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; Univ Pompeu Fabra UPF, Barcelona, Spainb ISGlobal, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; Univ Pompeu Fabra UPF, Barcelona, Spain; IMIM Hosp del Mar Res Inst, Barcelona, Spain4 org
773t Clinical and Translational Allergyd : Wileyg 10:1q 10:1x 2045-7022
856u https://doi.org/10.1186/s13601-020-00342-xy Fulltext
856u https://uu.diva-portal.org/smash/get/diva2:1519787/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://ctajournal.biomedcentral.com/track/pdf/10.1186/s13601-020-00342-x
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-432374
8564 8u https://doi.org/10.1186/s13601-020-00342-x
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:145407474

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy